Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD

Erica Osborn4 enrolled

Overview

This is a project that will determine whether the use of daily bright light therapy has an effect on depressive symptoms experienced by adult inpatients with CF and COPD. The purpose of this project is to apply a daily 30-minute BLT intervention to hospitalized adult CF and COPD patients in order to decrease symptoms of depression as measured by depression inventory scoring.

This project will occur on a 29-bed pulmonary step-down unit at a 1,600-bed academic medical center. This unit commonly treats patients with CF, COPD, and other pulmonary complications. The unit's patient care staff will be educated on the bright light lamps in order to prevent interruptions and to encourage compliance.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Cystic Fibrosis Depressive Symptoms Chronic Obstructive Pulmonary Disease

Interventions

Bright Light Therapy (BLT) LampDEVICE

With its built in automatic timer shut-off function, the bedside registered nurse (RN) would not need to return to the room to turn off this lamp after 30 minutes because the lamp will automatically shut off on its own.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with cystic fibrosis or chronic obstructive pulmonary disease (COPD) * Adult age 18 or older * Admitted to the pulmonary step-down and transplant unit * Score greater than zero on pre-intervention Beck's Depression Inventory-II (BDI-II) Exclusion Criteria: * Pre-existing ophthalmological conditions or photosensitivity * Migraines * Receiving high dose steroids for transplant rejection (due to mood altering qualities), * Antibiotics that increase light sensitivity * Diagnosed with bipolar disorder (light therapy may trigger mania) * Admissions anticipated to span less than 48 hours * Children are being excluded due to the fact that only adult CF and COPD subjects are admitted to University of Pittsburgh Medical Center (UPMC) Presbyterian hospital

Locations (2)

University of Pittsburgh Medical Center Presbyterian Hospital

Pittsburgh, Pennsylvania, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Outcomes

Primary Outcomes

Change in Pre- and Post-intervention Beck's Depression Inventory II Scores (BDI-II)

Change between pre-intervention and post-intervention self-reported answer totals to the 21 scored items on BDI-II (minimum score obtainable=0 (absent symptoms); maximum score obtainable=63 (most severe symptoms).

Time frame: First at time of admission, second at end of 7 day goal or upon discharge.

Secondary Outcomes

Number of Days Until Completion of Daily Bright Light Therapy (BLT)

The RN will sign a daily log indicating what time therapy was initiated and if therapy was refused. These logs will be collected from patient doors at the end of each week by the principal investigator (PI) in order to measure compliance with completion of therapy on a daily basis.

Time frame: Daily for duration of intervention period (goal/maximum of 7 days).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.